Article Details
Retrieved on: 2024-05-08 15:53:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
FUSN stock results show that Fusion Pharmaceuticals missed analyst estimates for earnings per share the first quarter of 2024.
Article found on: investorplace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here